Sonic Healthcare Limited (ASX:SHL)

Market Cap	11.53B
Revenue (ttm)	9.65B
Net Income (ttm)	513.60M
Shares Out	494.24M
EPS (ttm)	1.07
PE Ratio	21.87
Forward PE	18.87
Dividend	1.07 (4.58%)
Ex-Dividend Date	Sep 3, 2025

Volume	929,002
Average Volume	1,803,385
Open	23.25
Previous Close	23.35
Day's Range	23.10 - 23.42
52-Week Range	20.50 - 29.35
Beta	0.51
RSI	69.23
Earnings Date	Nov 19, 2025

About Sonic Healthcare

Sonic Healthcare Limited offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1934
• Employees: 45,000
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: SHL

Financial Performance

In 2025, Sonic Healthcare's revenue was 9.65 billion, an increase of 7.56% compared to the previous year's 8.97 billion. Earnings were 513.60 million, an increase of 0.49%.